em 523 has been researched along with ondansetron in 2 studies
| Studies (em 523) | Trials (em 523) | Recent Studies (post-2010) (em 523) | Studies (ondansetron) | Trials (ondansetron) | Recent Studies (post-2010) (ondansetron) |
|---|---|---|---|---|---|
| 26 | 1 | 0 | 3,380 | 1,216 | 994 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haga, N; Inatomi, N; Itoh, Z; Mizumoto, A; Shiba, Y; Yamamoto, O | 1 |
| Inui, A; Itoh, Z; Mizumoto, A; Omura, S; Satoh, M; Shiba, Y | 1 |
2 other study(ies) available for em 523 and ondansetron
| Article | Year |
|---|---|
Stimulatory mechanism of EM523-induced contractions in postprandial stomach of conscious dogs.
Topics: Animals; Anti-Bacterial Agents; Atropine; Dipeptides; Dogs; Dopamine; Eating; Erythromycin; Hexamethonium; Indoles; Motilin; Muscle Contraction; Naloxone; Ondansetron; Serotonin Antagonists; Stomach; Substance P | 1995 |
Effect of nonpeptide motilin agonist EM523 on release of gut and pancreatic hormones in conscious dogs.
Topics: Animals; Atropine; Dogs; Erythromycin; Gastrointestinal Hormones; Motilin; Ondansetron; Pancreatic Hormones; Serotonin Antagonists; Vagotomy | 1996 |